 | • レポートコード：MRC2-11QY11351 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はクラミジア診断・治療のグローバル市場について調査・分析したレポートです。種類別（クラミジア培養、尿培養、酵素イムノアッセイ、核酸増幅検査）市場規模、用途別（病院、診断センター、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別クラミジア診断・治療の競争状況、市場シェア ・世界のクラミジア診断・治療市場：種類別市場規模 2015年-2020年（クラミジア培養、尿培養、酵素イムノアッセイ、核酸増幅検査） ・世界のクラミジア診断・治療市場：種類別市場規模予測 2021年-2026年（クラミジア培養、尿培養、酵素イムノアッセイ、核酸増幅検査） ・世界のクラミジア診断・治療市場：用途別市場規模 2015年-2020年（病院、診断センター、研究機関） ・世界のクラミジア診断・治療市場：用途別市場規模予測 2021年-2026年（病院、診断センター、研究機関） ・北米のクラミジア診断・治療市場分析：米国、カナダ ・ヨーロッパのクラミジア診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのクラミジア診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のクラミジア診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのクラミジア診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Hologic、LabCorp、Novartis、Qiagen、Quidel、Roche Diagnostics、Siemens、Synapse Diagnostics、Sysmex、Thermo Fisher Scientific、Tosoh ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Chlamydia trachomatis is a type of sexually transmitted disease that is prevalent in population of all age group, but women are much more vulnerable to it. The Chlamydia diagnosis involves a series of test such as urine culture,
The change in lifestyle especially related to sex preferences is the major factor driving the growth of this market, moreover, the increase in use of rapid point of care diagnosis kits also propel the market.
Market Analysis and Insights: Global Chlamydia Diagnosis and Treatment Market
The global Chlamydia Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Chlamydia Diagnosis and Treatment Scope and Market Size
Chlamydia Diagnosis and Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chlamydia Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Hologic
LabCorp
Novartis
Qiagen
Quidel
Roche Diagnostics
Siemens
Synapse Diagnostics
Sysmex
Thermo Fisher Scientific
Tosoh
Market segment by Type, the product can be split into
Chlamydia culture
Urine culture
Enzyme immunoassays
Nucleic acid amplification test
Market segment by Application, split into
Hospitals
Diagnostic centres
Research institutions
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chlamydia Diagnosis and Treatment Revenue
1.4 Market by Type
1.4.1 Global Chlamydia Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chlamydia culture
1.4.3 Urine culture
1.4.4 Enzyme immunoassays
1.4.5 Nucleic acid amplification test
1.5 Market by Application
1.5.1 Global Chlamydia Diagnosis and Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic centres
1.5.4 Research institutions
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Chlamydia Diagnosis and Treatment Market Perspective (2015-2026)
2.2 Global Chlamydia Diagnosis and Treatment Growth Trends by Regions
2.2.1 Chlamydia Diagnosis and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chlamydia Diagnosis and Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Chlamydia Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chlamydia Diagnosis and Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Chlamydia Diagnosis and Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chlamydia Diagnosis and Treatment Players by Market Size
3.1.1 Global Top Chlamydia Diagnosis and Treatment Players by Revenue (2015-2020)
3.1.2 Global Chlamydia Diagnosis and Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Chlamydia Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chlamydia Diagnosis and Treatment Market Concentration Ratio
3.2.1 Global Chlamydia Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chlamydia Diagnosis and Treatment Revenue in 2019
3.3 Chlamydia Diagnosis and Treatment Key Players Head office and Area Served
3.4 Key Players Chlamydia Diagnosis and Treatment Product Solution and Service
3.5 Date of Enter into Chlamydia Diagnosis and Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chlamydia Diagnosis and Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chlamydia Diagnosis and Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020)
5.2 Global Chlamydia Diagnosis and Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chlamydia Diagnosis and Treatment Market Size (2015-2020)
6.2 Chlamydia Diagnosis and Treatment Key Players in North America (2019-2020)
6.3 North America Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020)
6.4 North America Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chlamydia Diagnosis and Treatment Market Size (2015-2020)
7.2 Chlamydia Diagnosis and Treatment Key Players in Europe (2019-2020)
7.3 Europe Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020)
7.4 Europe Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020)
8 China
8.1 China Chlamydia Diagnosis and Treatment Market Size (2015-2020)
8.2 Chlamydia Diagnosis and Treatment Key Players in China (2019-2020)
8.3 China Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020)
8.4 China Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chlamydia Diagnosis and Treatment Market Size (2015-2020)
9.2 Chlamydia Diagnosis and Treatment Key Players in Japan (2019-2020)
9.3 Japan Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020)
9.4 Japan Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chlamydia Diagnosis and Treatment Market Size (2015-2020)
10.2 Chlamydia Diagnosis and Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020)
11 India
11.1 India Chlamydia Diagnosis and Treatment Market Size (2015-2020)
11.2 Chlamydia Diagnosis and Treatment Key Players in India (2019-2020)
11.3 India Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020)
11.4 India Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chlamydia Diagnosis and Treatment Market Size (2015-2020)
12.2 Chlamydia Diagnosis and Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020)
12.4 Central & South America Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Chlamydia Diagnosis and Treatment Introduction
13.1.4 Abbott Laboratories Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Hologic
13.2.1 Hologic Company Details
13.2.2 Hologic Business Overview
13.2.3 Hologic Chlamydia Diagnosis and Treatment Introduction
13.2.4 Hologic Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
13.2.5 Hologic Recent Development
13.3 LabCorp
13.3.1 LabCorp Company Details
13.3.2 LabCorp Business Overview
13.3.3 LabCorp Chlamydia Diagnosis and Treatment Introduction
13.3.4 LabCorp Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
13.3.5 LabCorp Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Chlamydia Diagnosis and Treatment Introduction
13.4.4 Novartis Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Qiagen
13.5.1 Qiagen Company Details
13.5.2 Qiagen Business Overview
13.5.3 Qiagen Chlamydia Diagnosis and Treatment Introduction
13.5.4 Qiagen Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
13.5.5 Qiagen Recent Development
13.6 Quidel
13.6.1 Quidel Company Details
13.6.2 Quidel Business Overview
13.6.3 Quidel Chlamydia Diagnosis and Treatment Introduction
13.6.4 Quidel Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
13.6.5 Quidel Recent Development
13.7 Roche Diagnostics
13.7.1 Roche Diagnostics Company Details
13.7.2 Roche Diagnostics Business Overview
13.7.3 Roche Diagnostics Chlamydia Diagnosis and Treatment Introduction
13.7.4 Roche Diagnostics Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
13.7.5 Roche Diagnostics Recent Development
13.8 Siemens
13.8.1 Siemens Company Details
13.8.2 Siemens Business Overview
13.8.3 Siemens Chlamydia Diagnosis and Treatment Introduction
13.8.4 Siemens Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
13.8.5 Siemens Recent Development
13.9 Synapse Diagnostics
13.9.1 Synapse Diagnostics Company Details
13.9.2 Synapse Diagnostics Business Overview
13.9.3 Synapse Diagnostics Chlamydia Diagnosis and Treatment Introduction
13.9.4 Synapse Diagnostics Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
13.9.5 Synapse Diagnostics Recent Development
13.10 Sysmex
13.10.1 Sysmex Company Details
13.10.2 Sysmex Business Overview
13.10.3 Sysmex Chlamydia Diagnosis and Treatment Introduction
13.10.4 Sysmex Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
13.10.5 Sysmex Recent Development
13.11 Thermo Fisher Scientific
10.11.1 Thermo Fisher Scientific Company Details
10.11.2 Thermo Fisher Scientific Business Overview
10.11.3 Thermo Fisher Scientific Chlamydia Diagnosis and Treatment Introduction
10.11.4 Thermo Fisher Scientific Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
10.11.5 Thermo Fisher Scientific Recent Development
13.12 Tosoh
10.12.1 Tosoh Company Details
10.12.2 Tosoh Business Overview
10.12.3 Tosoh Chlamydia Diagnosis and Treatment Introduction
10.12.4 Tosoh Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020)
10.12.5 Tosoh Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Chlamydia Diagnosis and Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Chlamydia Diagnosis and Treatment Revenue
Table 3. Ranking of Global Top Chlamydia Diagnosis and Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chlamydia Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chlamydia culture
Table 6. Key Players of Urine culture
Table 7. Key Players of Enzyme immunoassays
Table 8. Key Players of Nucleic acid amplification test
Table 9. Global Chlamydia Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Chlamydia Diagnosis and Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Chlamydia Diagnosis and Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Chlamydia Diagnosis and Treatment Market Share by Regions (2015-2020)
Table 13. Global Chlamydia Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Chlamydia Diagnosis and Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Chlamydia Diagnosis and Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Chlamydia Diagnosis and Treatment Players
Table 20. Global Chlamydia Diagnosis and Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Chlamydia Diagnosis and Treatment Market Share by Players (2015-2020)
Table 22. Global Top Chlamydia Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chlamydia Diagnosis and Treatment as of 2019)
Table 23. Global Chlamydia Diagnosis and Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Chlamydia Diagnosis and Treatment Product Solution and Service
Table 26. Date of Enter into Chlamydia Diagnosis and Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Chlamydia Diagnosis and Treatment Market Size Share by Type (2015-2020)
Table 30. Global Chlamydia Diagnosis and Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Chlamydia Diagnosis and Treatment Market Size Share by Application (2015-2020)
Table 32. Global Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Chlamydia Diagnosis and Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Chlamydia Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Chlamydia Diagnosis and Treatment Market Share (2019-2020)
Table 36. North America Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Chlamydia Diagnosis and Treatment Market Share by Type (2015-2020)
Table 38. North America Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Chlamydia Diagnosis and Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Chlamydia Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Chlamydia Diagnosis and Treatment Market Share (2019-2020)
Table 42. Europe Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Chlamydia Diagnosis and Treatment Market Share by Type (2015-2020)
Table 44. Europe Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Chlamydia Diagnosis and Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Chlamydia Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Chlamydia Diagnosis and Treatment Market Share (2019-2020)
Table 48. China Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Chlamydia Diagnosis and Treatment Market Share by Type (2015-2020)
Table 50. China Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Chlamydia Diagnosis and Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Chlamydia Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Chlamydia Diagnosis and Treatment Market Share (2019-2020)
Table 54. Japan Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Chlamydia Diagnosis and Treatment Market Share by Type (2015-2020)
Table 56. Japan Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Chlamydia Diagnosis and Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Chlamydia Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Chlamydia Diagnosis and Treatment Market Share (2019-2020)
Table 60. Southeast Asia Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Chlamydia Diagnosis and Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Chlamydia Diagnosis and Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Chlamydia Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Chlamydia Diagnosis and Treatment Market Share (2019-2020)
Table 66. India Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Chlamydia Diagnosis and Treatment Market Share by Type (2015-2020)
Table 68. India Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Chlamydia Diagnosis and Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Chlamydia Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Chlamydia Diagnosis and Treatment Market Share (2019-2020)
Table 72. Central & South America Chlamydia Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Chlamydia Diagnosis and Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Chlamydia Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Chlamydia Diagnosis and Treatment Market Share by Application (2015-2020)
Table 76. Abbott Laboratories Company Details
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Product
Table 79. Abbott Laboratories Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 80. Abbott Laboratories Recent Development
Table 81. Hologic Company Details
Table 82. Hologic Business Overview
Table 83. Hologic Product
Table 84. Hologic Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 85. Hologic Recent Development
Table 86. LabCorp Company Details
Table 87. LabCorp Business Overview
Table 88. LabCorp Product
Table 89. LabCorp Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 90. LabCorp Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Qiagen Company Details
Table 97. Qiagen Business Overview
Table 98. Qiagen Product
Table 99. Qiagen Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 100. Qiagen Recent Development
Table 101. Quidel Company Details
Table 102. Quidel Business Overview
Table 103. Quidel Product
Table 104. Quidel Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 105. Quidel Recent Development
Table 106. Roche Diagnostics Company Details
Table 107. Roche Diagnostics Business Overview
Table 108. Roche Diagnostics Product
Table 109. Roche Diagnostics Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 110. Roche Diagnostics Recent Development
Table 111. Siemens Business Overview
Table 112. Siemens Product
Table 113. Siemens Company Details
Table 114. Siemens Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 115. Siemens Recent Development
Table 116. Synapse Diagnostics Company Details
Table 117. Synapse Diagnostics Business Overview
Table 118. Synapse Diagnostics Product
Table 119. Synapse Diagnostics Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 120. Synapse Diagnostics Recent Development
Table 121. Sysmex Company Details
Table 122. Sysmex Business Overview
Table 123. Sysmex Product
Table 124. Sysmex Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 125. Sysmex Recent Development
Table 126. Thermo Fisher Scientific Company Details
Table 127. Thermo Fisher Scientific Business Overview
Table 128. Thermo Fisher Scientific Product
Table 129. Thermo Fisher Scientific Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 130. Thermo Fisher Scientific Recent Development
Table 131. Tosoh Company Details
Table 132. Tosoh Business Overview
Table 133. Tosoh Product
Table 134. Tosoh Revenue in Chlamydia Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 135. Tosoh Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chlamydia Diagnosis and Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chlamydia culture Features
Figure 3. Urine culture Features
Figure 4. Enzyme immunoassays Features
Figure 5. Nucleic acid amplification test Features
Figure 6. Global Chlamydia Diagnosis and Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic centres Case Studies
Figure 9. Research institutions Case Studies
Figure 10. Chlamydia Diagnosis and Treatment Report Years Considered
Figure 11. Global Chlamydia Diagnosis and Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Chlamydia Diagnosis and Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Chlamydia Diagnosis and Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Chlamydia Diagnosis and Treatment Market Share by Players in 2019
Figure 16. Global Top Chlamydia Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chlamydia Diagnosis and Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Chlamydia Diagnosis and Treatment Revenue in 2019
Figure 18. North America Chlamydia Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Chlamydia Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Chlamydia Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Chlamydia Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Chlamydia Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Chlamydia Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Chlamydia Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
クラミジア感染症診断・治療の世界市場（～2026年） The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities. Market Analysis and Insights: Global Chlamydia Infection Diagnostics and Therapeutics Market The global Chlamydia Infection Diagnostics and The…- 髄膜炎診断・治療の世界市場（～2026年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …
- HIV診断・治療の世界市場（～2026年） HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is l…
- ミトコンドリアミオパチー診断・治療の世界市場（～2026年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…
- 癲癇診断・治療の世界市場（～2026年） Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …